Oric Pharmaceuticals Inc share price logo

Oric Pharmaceuticals Inc

NASDAQ: ORIC

Small Cap

$8.97

+0.53

(+6.21%)

as on

Oric Pharmaceuticals Inc Stock Performance

as on June 2, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $8.24
    $9.13
    downward going graph

    8.14%

    Downside

    1.78%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.23
    $14.93
    downward going graph

    19.40%

    Downside

    66.44%

    Upside

    downward going graph

Oric Pharmaceuticals Inc share price movements today

Previous Close
$8.45
Open
$8.34
Volume
3.3M
Day's Low - High
$8.24 - $9.13
52 Week Low - High
$7.23 - $14.93

Oric Pharmaceuticals Inc Historical Returns

1 Month Return
-13.51 %
3 Month Return
-37.17 %
1 Year Return
+ 3.43 %
3 Year Return
+ 60.34 %
5 Year Return
-63.32 %

Oric Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Oric Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$874.7M

EPS (TTM)

-1.4542

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-148.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-42.57%

Oric Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oric Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$874.7M-63.32%NA0.00%NA
BUY$33.5B421.11%NA0.00%NA
BUY$40.3B109.3%75.6812.55%NA
BUY$113.6B113.45%26.5335.51%NA
BUY$64.5B22.17%15.0229.65%0.58%

Stock Returns calculator for Oric Pharmaceuticals Inc Stock including INR - Dollar returns

The Oric Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Oric Pharmaceuticals Inc investment value today

Current value as on today

₹1,22,188

Returns

₹22,188

(+22.19%)

Returns from Oric Pharmaceuticals Inc Stock

₹9,792 (+9.79%)

Dollar Impact

₹12,396 (+12.4%)

Analyst Recommendation on Oric Pharmaceuticals Inc Stock

Based on 15 analysts

BUY

93.33%

Buy

6.67%

Hold

0.00%

Sell

Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Oric Pharmaceuticals Inc. Average target price of $20.36

Oric Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Oric Pharmaceuticals Inc.

What analysts predicted

55.94%UPSIDE

Target Price

$20.36

Current Price

$8.97

Analyzed by

15 Analysts

Target

$20.36

Oric Pharmaceuticals Inc target price $20.36, a slight upside of 55.94% compared to current price of $8.97. According to 15 analysts rating.

Indian Investors' Interest in Oric Pharmaceuticals Inc Stock

Search interest for Oric Pharmaceuticals Inc Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-48% versus previous 30 day period

Oric Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1
-
-
-
1
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
-
0
-
Operating Income
-31
-28
-36
-38
-39
-32
-39
-36
-34
-39
EBITDA
-28
-28
-35
-38
-36
-32
-38
-32
-30
-39
Interest Expense
1
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-28
-25
-31
-34
-36
-30
-36
-32
-30
-35
Income Tax Expense
2
0
0
-
-
-
-
-
-
-
Net Income
-28
-25
-31
-34
-36
-30
-36
-32
-30
-35
Net Profit Margin
-1842.00%
0.00%
0.00%
0.00%
-3405.91%
0.00%
0.00%
0.00%
0.00%
0.00%

Oric Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
-1
0
0
0
-1
-1
-1
Operating Income
-22
-28
-74
-78
-91
-110
-142
-143
EBITDA
-20
-25
-48
-77
-85
-109
-126
-128
Interest Expense
1
1
0
0
2
-
-
-
Depreciation
0
1
0
0
0
1
1
1
Income Before Tax
-21
-26
-73
-78
-89
-100
-127
-129
Income Tax Expense
-1
-1
23
-1
2
-
-
-
Net Income
-21
-26
-73
-77
-89
-100
-127
-129
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Oric Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-25
-31
-34
-36
-30
-36
-32
-30
-35
Operating Cash Flow
-30
-25
-28
-28
-32
-30
-25
-22
-32
Investing Cash Flow
-61
18
23
42
22
-76
-110
16
-17
Financing Cash Flow
125
0
0
0
0
134
109
1
61
Change in Cash
32
-6
-5
15
-10
26
-26
-3
10

Oric Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-21
-26
-73
-78
-89
-100
-127
-129
Operating Cash Flow
-20
-23
-45
-59
-75
-85
-112
-113
Investing Cash Flow
0
0
-215
158
-109
-43
22
-148
Financing Cash Flow
38
70
250
49
25
85
126
247
Change in Cash
16
46
-10
148
-159
-43
36
-13

Global Institutional Holdings in Oric Pharmaceuticals Inc

Funds
Holdings
Viking Global Investors LP
6.35%
Viking Global Investors LP
5.63%
Alkeon Capital Management, LLC
4.35%
BlackRock Inc
5.68%
SR ONE CAPITAL MANAGEMENT, LP
4.36%

Insights on Oric Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 287.4% return, outperforming this stock by 287.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 515.9% return, outperforming this stock by 457.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ORIC stock has moved down by -39.1%

About Oric Pharmaceuticals Inc

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States. Its clinical stage product candidates include enozertinib formerly known as ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 and human epidermal growth factor receptor 2 exon 20 with high potency towards exon 20 insertion mutations; and rinzimetostat formerly known as ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study. It has a clinical trial collaboration and supply agreement with Bayer to evaluate ORIC-944 in combination with Nubeqa AR inhibitor; and a clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC 944 in combination with Erleada AR inhibitor. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
OrganisationOric Pharmaceuticals Inc
Headquarters240 E. Grand Ave, South San Francisco, CA, United States, 94080
IndustryBiotechnology
CEODr. Jacob M. Chacko M.B.A., M.D.
E-voting on sharesClick here to vote

Key Management of Oric Pharmaceuticals Inc

Name

Title

Dr. Charles L. Sawyers B.A., M.D., Ph.D.

Founder & Member of Scientific Advisory Board

Dr. Scott W. Lowe Ph.D.

Founder & Member of Scientific Advisory Board

Dr. Lori Sickels Friedman Ph.D.

Chief Scientific Officer

Dr. Christian V. Kuhlen Esq., J.D., M.D.

General Counsel

Mr. Daniel Iazzetti

VP & Head of People

Dr. Pratik S. Multani M.D., M.S.

Chief Medical Officer

Dr. Jacob M. Chacko M.B.A., M.D.

President, CEO & Director

Mr. Dominic G. Piscitelli CPA, M.B.A.

Chief Financial Officer

Dr. Kevin Brodbeck Ph.D.

Chief Technical Officer

Dr. Richard A. Heyman Ph.D.

Founder, Independent Chairman & Member of Scientific Advisory Board

FAQs

What is Oric Pharmaceuticals Inc share price today?

Oric Pharmaceuticals Inc share price today is $8.97 as on at the close of the market. Oric Pharmaceuticals Inc share today touched a day high of $9.13 and a low of $8.24.

What is the 52 week high and 52 week low for Oric Pharmaceuticals Inc share?

Oric Pharmaceuticals Inc share touched a 52 week high of $14.93 on and a 52 week low of $7.23 on . Oric Pharmaceuticals Inc stock price today i.e. is closed at $8.97,which is 39.92% down from its 52 week high and 24.07% up from its 52 week low.

What is Oric Pharmaceuticals Inc's market capitalisation today?

Oric Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Oric Pharmaceuticals Inc Stock (ORIC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Oric Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oric Pharmaceuticals Inc Shares that will get you 0.1672 shares as per Oric Pharmaceuticals Inc share price of $8.97 per share as on June 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy Oric Pharmaceuticals Inc Stock (ORIC) from India?

Indian investors can start investing in Oric Pharmaceuticals Inc (ORIC) shares with as little as ₹94.99 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.90 in Oric Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Oric Pharmaceuticals Inc share’s latest price of $8.97 as on June 2, 2026 at 1:29 am IST, you will get 1.1148 shares of Oric Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Oric Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Oric Pharmaceuticals Inc stock has given -63.32% share price returns and 30.39% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?